122 related articles for article (PubMed ID: 1003517)
1. Effect of zinc administration on the growth of L1210 and BW5147 tumors in mice.
Phillips JL; Sheridan PJ
J Natl Cancer Inst; 1976 Aug; 57(2):361-3. PubMed ID: 1003517
[TBL] [Abstract][Full Text] [Related]
2. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
Razek A; Vietti T; Valeriote F
Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
[No Abstract] [Full Text] [Related]
3. [Effect of Brucella abortus infection on the development of Rauscher and L1210 leukemias in mice].
Veskova TK; Chimishkian KL; Svet-Moldavskiĭ GIa
Vopr Virusol; 1973; 18(6):728-31. PubMed ID: 4789989
[No Abstract] [Full Text] [Related]
4. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
Santelli G; Valeriote F
J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
[TBL] [Abstract][Full Text] [Related]
5. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
6. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
Yancey ST; Bleyer WA
Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
[No Abstract] [Full Text] [Related]
7. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
Marks TA; Venditti JM
Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer activity of the extracts of stem and leaf of Tylophora indica.
Chitnis MP; Khandalekar DD; Adwankar MK; Sahasrabudhe MB
Indian J Med Res; 1972 Mar; 60(3):359-62. PubMed ID: 4659916
[No Abstract] [Full Text] [Related]
9. [Antileukemic activity of carminomycin complexes with a high-polymer DNA].
Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK
Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenicity and anti-cancer properties of n-hydroxy urethan.
Bhide SV; Khandalekar DD; Chitnis MP; Arjungi KN; Sirsat MV
Indian J Cancer; 1974 Dec; 11(4):462-6. PubMed ID: 4468254
[No Abstract] [Full Text] [Related]
11. Attempted use of zinc in vivo to protect against nitrogen mustard toxicity in tumor-free and in L1210 leukemia-bearing female B6D2F1 mice.
Shackelford ME; Tobey RA
J Appl Toxicol; 1992 Aug; 12(4):295-300. PubMed ID: 1430782
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC
Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
[No Abstract] [Full Text] [Related]
13. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
Israel M; Modest EJ; Frei E
Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
[TBL] [Abstract][Full Text] [Related]
14. Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells.
Skórski T; Ratajczak MZ; Kawalec M; Kawiak J
Folia Histochem Cytobiol; 1991; 29(3):121-4. PubMed ID: 1794437
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of human and animal acute leukemia.
Goldin A; Sandberg JS; Henderson ES; Newman JW; Frei E; Holland JF
Cancer Chemother Rep; 1971 Nov; 55(4):309-505. PubMed ID: 4945857
[No Abstract] [Full Text] [Related]
16. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).
Woodman RJ; Cysyk RL; Kline I; Gang M; Venditti JM
Cancer Chemother Rep; 1975; 59(4):689-95. PubMed ID: 1175163
[TBL] [Abstract][Full Text] [Related]
18. R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness.
Atassi G; Tagnon HJ
Eur J Cancer (1965); 1975 Sep; 11(9):599-607. PubMed ID: 1220975
[No Abstract] [Full Text] [Related]
19. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
McGovren JP
Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice.
Valeriote F; Medoff G; Tolen S; Dieckman J
J Natl Cancer Inst; 1984 Aug; 73(2):475-82. PubMed ID: 6589439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
